The PE Ratio as of June 2026 (TTM) for Entasis Therapeutics Holdings Inc. (ETTX) is -1.95

According to Entasis Therapeutics Holdings Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.95. This represents a change of 4.24% compared to the average of -1.87 of the last 4 quarters.

Entasis Therapeutics Holdings Inc. (ETTX) Historical PE Ratio (quarterly & annually)

How has ETTX PE Ratio performed in the past?

The mean historical PE Ratio of Entasis Therapeutics Holdings Inc. over the last ten years is -1.45. The current -1.95 PE Ratio has changed 13.37% with respect to the historical average. Over the past ten years (40 quarters), ETTX's PE Ratio was at its highest in in the September 2018 quarter at -0.26. The PE Ratio was at its lowest in in the June 2018 quarter at -5.77.

Entasis Therapeutics Holdings Inc. (ETTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Entasis Therapeutics Holdings Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Entasis Therapeutics Holdings Inc. (ETTX) Average PE Ratio

How has ETTX PE Ratio performed in the past?

The current PE Ratio of Entasis Therapeutics Holdings Inc. (ETTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Entasis Therapeutics Holdings Inc. (ETTX) PE Ratio vs. Peers

How is ETTX’s PE Ratio compared to its peers?

Entasis Therapeutics Holdings Inc.’s PE Ratio is greater than HilleVax, Inc. (-2.31), less than Jounce Therapeutics, Inc. (-1.91), greater than Cyteir Therapeutics, Inc. (-2.42), less than RVL Pharmaceuticals plc (-0.05), less than Opiant Pharmaceuticals, Inc. (30.58), greater than Tourmaline Bio, Inc. (-18.09), less than Paratek Pharmaceuticals, Inc. (-1.91), greater than Aadi Bioscience, Inc. (-2.49), less than Decibel Therapeutics, Inc. (-1.95), greater than Miromatrix Medical Inc. (-2.34),

Build a custom stock screener for Entasis Therapeutics Holdings Inc. (ETTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Entasis Therapeutics Holdings Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Entasis Therapeutics Holdings Inc. (ETTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Entasis Therapeutics Holdings Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.